University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
NIH and Prostate Cancer Foundation Launch Large Study on Aggressive Prostate Cancer in African-American Men

NIH and Prostate Cancer Foundation Launch Large Study on Aggressive Prostate Cancer in African-American Men

July 17, 2018

UCSF is one of four NCI cancer centers leading a large national study of African American men with aggressive prostate cancer. The RESPOND study, which will examine links between aggressive disease and environmental and genetic factors, aims to enroll 10,000 men.The following press release ...
Breast Cancer Follow-Up Imaging Varies Widely, Study Finds

Breast Cancer Follow-Up Imaging Varies Widely, Study Finds

July 13, 2018

Follow-up imaging for women with non-metastatic breast cancer varies widely across the country, according to a new study led by researchers at UC San Francisco. Some patients go without the annual mammograms that experts recommend, while others with the same cancer diagnosis receive full-body scans ...
Investigator Celebrates Collaboration and the 'X' in Cancer Research at UCSF

Investigator Celebrates Collaboration and the 'X' in Cancer Research at UCSF

July 12, 2018

Successful cancer centers like the HDFCCC place a premium on interdisciplinary collaboration. With labs, clinics and offices spread among three UCSF campuses, leadership and members continually devise ways to overcome the geographic separation. Jeroen Roose, co-leads the Parnassus Cancer Research Steering Committee and worked with ...
T Cell Engineering Breakthrough Sidesteps Need for Viruses in Gene-Editing

T Cell Engineering Breakthrough Sidesteps Need for Viruses in Gene-Editing

July 11, 2018

In an achievement that has significant implications for research, medicine, and industry, UC San Francisco scientists have genetically reprogrammed the human immune cells known as T cells without using viruses to insert DNA. The researchers said they expect their technique—a rapid, versatile, and economical approach ...
Deadly Form of Advanced Prostate Cancer Is Common, Calls for Distinct Treatment

Deadly Form of Advanced Prostate Cancer Is Common, Calls for Distinct Treatment

July 9, 2018

A new study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that a surprisingly large number of these cancers – about 17 percent – belong to a deadlier subtype of metastatic prostate cancer.  Previously, it was ...
Evolution of Melanoma Reveals Opportunities for Intervention

Evolution of Melanoma Reveals Opportunities for Intervention

July 9, 2018

UC San Francisco researchers have identified the sequence of genetic changes that transform benign moles to into malignant skin cancer and have used CRISPR gene editing to recreate the steps of melanoma evolution one by one in normal human skin cells in the lab. The ...